NEW YORK – Startup DiagMetrics plans to parlay novel sample collection and detection technologies into home-use and point of care tests. The Madison, Connecticut-based company was recently awarded funding to develop easy-to-use mask-based COVID-19 assays for people with disabilities and intends to bring other infectious disease and critical care tests to the clinical and over-the-counter market.
John Daniels, an engineer, inventor, and registered US patent attorney who now serves as Diagmetric’s CEO, said in an interview that the genesis of the firm came from his experience nursing his elderly parents through SARS-CoV-2 infections.
“They had both contracted COVID in their 90s, right at the beginning of the pandemic,” he said.
With that, Daniels set about determined to develop a platform diagnostic that could be used at home and improve upon the low sensitivity of standard lateral flow immunoassays and high complexity of lab-based molecular testing.
In 2020, he, along with Ken DeCubellis, and Shekhar Wadekar, cofounded DiagMetrics.
To read the complete article, down load the PDF below.
This article was originally published on 360Dx in Aug, 2023. Click here to download a PDF of the full article.
